ALTS vs IMMR

ALTS exhibits severe financial distress signals, with a Piotroski F-Score of 2/9 indicating poor operational and financial health. The company's Altman Z-Score is unavailable, but its negative ROA (-1.71%), negative operating margin (-218.34%), and extremely low current ratio (0.80) suggest high bankruptcy risk. Despite strong revenue growth (53.3% YoY), profitability remains elusive, and the stock trades at a steep Price/Sales of 6.85, far above its low Price/Book of 0.11. The 52-week price range ($1.08–$10.95) and 5-year decline of 82.8% reflect deep investor skepticism, despite a single 'strong_buy' analyst recommendation.

IMMR presents a classic 'deep value' paradox: it is fundamentally undervalued based on the Graham Number ($19.63) and Intrinsic Value ($13.3), yet it is plagued by a total collapse in technical momentum (0/100). The Piotroski F-Score of 4/9 indicates stable but mediocre financial health, while a negative operating margin (-8.03%) suggests that strong revenue growth (59.2%) is not yet translating into operational efficiency. While the dividend is exceptionally safe with a 7.11% payout ratio, the recent massive earnings miss (-382.1% surprise) and consistent price decline suggest a value trap until a catalyst emerges.